Literature DB >> 31058285

Distinct Function-Related Molecular Profile of Adult Human A2B5-Positive Pre-Oligodendrocytes Versus Mature Oligodendrocytes.

Caroline Esmonde-White1, Moein Yaqubi1, Philippe A Bilodeau1, Qiao Ling Cui1, Florian Pernin1, Catherine Larochelle2, Mahtab Ghadiri3, Yu Kang T Xu1, Timothy E Kennedy1, Jeffery Hall4, Luke M Healy1, Jack P Antel1.   

Abstract

Remyelination in the human CNS is ascribed to progenitor cells rather than previously myelinating oligodendrocytes (OLs). The ganglioside-recognizing antibody A2B5 has been used to isolate putative progenitor cells, whose in vitro features resemble cells labeled as "pre-oligodendrocytes." Here, we compare the transcriptional profiles of adult human brain-derived A2B5 antibody-selected cells (A+) after initial isolation (day in vitro (DIV1)) and after DIV6, with nonselected (A-) cells (mature OLs), with regard to their differentiation state and functional properties. While a number of previously recognized progenitor associated genes, specifically PTPRZ1 and PDGFRα, were upregulated in the A2B5+ population, a number of such genes were comparably expressed in the mature OLs, as were mature myelin genes. Additional progenitor-related genes were upregulated in the A+ population. We show that A2B5+ cells have greater capacity to ensheath nanofibers, a model of myelination potential; consistent with this, ingenuity pathway analysis indicated that A+ cells had upregulated expression of genes within cell growth and cell signaling pathways. Differential expression of cell death/survival pathways complements previous functional studies showing their increased susceptibility to metabolic stress. At DIV6, we observed significantly fewer differentially expressed genes; suggestive of cell maturation occurring in vitro, indicating the complexity in comparing in vitro and in situ cell properties.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Cell movement and cell death pathways; Human oligodendrocytes; In vitro differentiation; Oligodendrocyte lineage associated genes; “Pre-oligodendrocytes.”

Mesh:

Substances:

Year:  2019        PMID: 31058285     DOI: 10.1093/jnen/nlz026

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

Review 1.  Immune cell regulation of glia during CNS injury and disease.

Authors:  Andrew D Greenhalgh; Sam David; F Chris Bennett
Journal:  Nat Rev Neurosci       Date:  2020-02-10       Impact factor: 34.870

2.  Age-related injury responses of human oligodendrocytes to metabolic insults: link to BCL-2 and autophagy pathways.

Authors:  Milton Guilherme Forestieri Fernandes; Julia Xiao Xuan Luo; Qiao-Ling Cui; Kelly Perlman; Florian Pernin; Moein Yaqubi; Jeffery A Hall; Roy Dudley; Myriam Srour; Charles P Couturier; Kevin Petrecca; Catherine Larochelle; Luke M Healy; Jo Anne Stratton; Timothy E Kennedy; Jack P Antel
Journal:  Commun Biol       Date:  2021-01-04

3.  Identifying the functions of two biomarkers in human oligodendrocyte progenitor cell development.

Authors:  Haipeng Zhou; Ying He; Zhaoyan Wang; Qian Wang; Caiyan Hu; Xiaohua Wang; Siliang Lu; Ke Li; Yinxiang Yang; Zuo Luan
Journal:  J Transl Med       Date:  2021-05-01       Impact factor: 8.440

4.  Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation.

Authors:  Catherine Larochelle; Beatrice Wasser; Hélène Jamann; Julian T Löffel; Qiao-Ling Cui; Olivier Tastet; Miriam Schillner; Dirk Luchtman; Jérôme Birkenstock; Albrecht Stroh; Jack Antel; Stefan Bittner; Frauke Zipp
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-24       Impact factor: 11.205

Review 5.  Understanding the Links among Maternal Diet, Myelination, and Depression: Preclinical and Clinical Overview.

Authors:  Irena Smaga
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

6.  Neural Epidermal Growth Factor-Like Like Protein 2 Is Expressed in Human Oligodendroglial Cell Types.

Authors:  Mohammed R Shaker; Amna Kahtan; Renuka Prasad; Ju-Hyun Lee; Giovanni Pietrogrande; Hannah C Leeson; Woong Sun; Ernst J Wolvetang; Andrii Slonchak
Journal:  Front Cell Dev Biol       Date:  2022-02-21

Review 7.  The Current Challenges for Drug Discovery in CNS Remyelination.

Authors:  Sonia Balestri; Alice Del Giovane; Carola Sposato; Marta Ferrarelli; Antonella Ragnini-Wilson
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.